AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

13,880.00p
   
  • Change Today:
    170.00p
  • 52 Week High: 15,316.00p
  • 52 Week Low: 10,120.00p
  • Currency: UK Pounds
  • Shares Issued: 1,551.00m
  • Volume: 1,319,247
  • Market Cap: £215,278m
  • RiskGrade: 123
  • Beta: 0.00

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
  4th Interim 00.00      
  3rd Interim 00.00      
31-Dec-22 1st Interim 93.00¢ 12-Sep-22 11-Aug-22 12-Aug-22
  2nd Interim 197.00¢ 27-Mar-23 23-Feb-23 24-Feb-23
  4th Interim 00.00      
  3rd Interim 00.00      
31-Dec-23 1st Interim 93.00¢ 11-Sep-23 10-Aug-23 11-Aug-23
  2nd Interim 197.00¢ 25-Mar-24 22-Feb-24 23-Feb-24
  4th Interim 00.00      
  3rd Interim 00.00      
31-Dec-24 1st Interim 100.00¢ 09-Sep-24 08-Aug-24 09-Aug-24
  2nd Interim 210.00¢ 24-Mar-25 20-Feb-25 21-Feb-25
  4th Interim 00.00      
  3rd Interim 00.00      
31-Dec-25 1st Interim 103.00¢ 08-Sep-25 07-Aug-25 08-Aug-25
  2nd Interim 217.00¢ 23-Mar-26 19-Feb-26 20-Feb-26

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

AstraZeneca Market Data

Currency UK Pounds
Share Price 13,880.00p
Change Today 170.00p
% Change 1.24 %
52 Week High 15,316.00p
52 Week Low 10,120.00p
Volume 1,319,247
Shares Issued 1,551.00m
Market Cap £215,278m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average94.66% below the market average
90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average90.24% below the sector average
Price Trend
9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average9.16% above the market average
45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average45.45% above the sector average
Income
68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average68.72% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average87.64% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 13
Neutral 3
Sell 0
Strong Sell 1
Total 27
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 19-Feb-26 07-Aug-25
Paid 23-Mar-26 08-Sep-25
Amount 217.00¢ 103.00¢

Trades for 19-May-2026

Time Volume / Share Price
16:20 0 @ 13,884.00p
16:27 0 @ 13,874.00p
16:48 366 @ 13,880.00p
15:42 0 @ 13,818.00p
16:39 1,834 @ 13,880.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page